The New Kid on the Block: A Retrospective Multicenter Real-World Experience with Maribavir for Cytomegalovirus Infection in Pediatric Transplant and Cellular Therapy Recipients
This multicenter retrospective case series characterizes maribavir (MBV) use for cytomegalovirus (CMV) infection in 62 immunocompromised children treated at 18 United States centers from 2015 through 2024. The most common indications for use were suspected antiviral resistance (45.2%), documented resistance (19.4%), and lack of appropriate alternative agents (11.3%). Among 59 participants with detectable CMV DNAemia when their first course began, 66.1% had complete response, 5.1% had partial response, 27.1% had no response, and one relapsed before treatment cessation. CMV DNAemia ≥50,000 IU/mL was associated with a lower response rate, and MBV resistance was identified in four participants. Across 70 total treatment episodes, 21.4% reported adverse events and discontinuation attributed to MBV occurred in 5.7%. Concomitant use of MBV and other anti-CMV directed medications occurred frequently. Although efficacy results are limited by the observational design, these results highlight real-world pediatric experience and safety.
Authors
- Claire Elizabeth Bocchini (ORCID: https://orcid.org/0000-0001-9577-8162)
- Eunkyung Song (ORCID: https://orcid.org/0000-0002-7907-957X)
- Kathryn P. Goggin (ORCID: https://orcid.org/0009-0001-0460-937X)
- Yeh-Chung Chang (ORCID: https://orcid.org/0000-0003-3073-4980)
- Elizabeth Doby Knackstedt (ORCID: https://orcid.org/0000-0001-5472-511X)
- Marc D. Foca (ORCID: https://orcid.org/0000-0002-1628-8446)
- Shannon L. Andrews (ORCID: https://orcid.org/0000-0002-9504-1336)
- Surabhi B Vora (ORCID: https://orcid.org/0000-0002-9344-5185)
- William R Otto (ORCID: https://orcid.org/0000-0001-7959-1445)
- Taylor A. Heald-Sargent (ORCID: https://orcid.org/0000-0003-0856-4006)
- Joana Dimo (ORCID: https://orcid.org/0009-0008-4279-0393)
- Jonathan D. Albert (ORCID: https://orcid.org/0000-0002-8966-6364)
- Diego R. Hijano (ORCID: https://orcid.org/0000-0002-2903-666X)
- Tanvi S Sharma (ORCID: https://orcid.org/0009-0005-3452-0666)
- Gabriela Maria Marón (ORCID: https://orcid.org/0000-0001-5247-5399)
- Benjamin R Hanisch (ORCID: https://orcid.org/0000-0003-3387-9093)
- Mary Suzanne Whitworth
- Lara A. Danziger‐Isakov (ORCID: https://orcid.org/0000-0002-5691-5221)
- Kari Neemann (ORCID: https://orcid.org/0000-0001-6476-5924)
- Antigone Kraft
- Madeline Johnson
- Kay Leopold
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Boston Children's Hospital (US)
- Lurie Children's Hospital (US)
- Seattle Children's Hospital (US)
- Albert Einstein College of Medicine (US)
- University of Minnesota (US)
- St. Jude Children's Research Hospital (US)
- Nationwide Children's Hospital (US)
- Children's National (US)
- Harvard University (US)
- Emory University (US)
- University of Pittsburgh (US)
- Baylor College of Medicine (US)
- George Washington University (US)
- University of Washington (US)
- University of Utah (US)
- University of Michigan (US)
- University of Minnesota System (US)
- University of Utah Hospital (US)
- Cook Children's Medical Center (US)
- Southwestern Medical Center (US)
- Cook Children's Health Care System (US)
- Lurie Children's Hospital (US)
- Children's Hospital of Pittsburgh (US)
- Children's Hospital at Montefiore (US)
- Children's Healthcare of Atlanta (US)
- University of Colorado Anschutz Medical Campus (US)
- The Ohio State University (US)
- University of Nebraska Medical Center (US)
- University of Cincinnati (US)
- The University of Texas Southwestern Medical Center (US)
- University of Cincinnati Medical Center (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1093/jpids/piag121
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00